Physician profile
Jonathan Peach
NPI 1316375041
$1,322.09
in general payments reported to CMS, 2019-2025
20 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $391 · 2022: $377 · 2023: $73.07 · 2024: $145 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $384.93 | 2023-2025 | Otezla, Otezla, Repatha |
| Lilly USA, LLC | $244.40 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $156.34 | 2021-2022 | |
| Glaxosmithkline, LLC. | $84.16 | 2021-2022 | |
| Novo Nordisk INC | $80.59 | 2021-2022 | |
| Pfizer INC. | $64.08 | 2021-2022 | |
| Abbott Laboratories | $47.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.07 | 2021-2023 | Jardiance |
| Vanda Pharmaceuticals INC. | $29.94 | 2023 | Hetlioz |
| Abbvie INC. | $29.77 | 2022 | |
| Amarin Pharma, INC. | $22.67 | 2022 | |
| Exact Sciences Corporation | $20.77 | 2025 | Cologuard Collection Kit |
| Phadia US INC. | $20.26 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.73 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.03 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.64 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.54 | 2022 | |
| Tolmar, INC. | $13.89 | 2025 | Jatenzo |
| Galderma Laboratories, L.P. | $12.54 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Peach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.